Yahoo Web Search

Search results

  1. People also ask

  2. en.wikipedia.org › wiki › NifurtimoxNifurtimox - Wikipedia

    Society and culture. Legal status. Names. Research. References. External links. Nifurtimox, sold under the brand name Lampit, is a medication used to treat Chagas disease and sleeping sickness. [2] [4] For sleeping sickness it is used together with eflornithine in nifurtimox-eflornithine combination treatment. [4] .

  3. Oct 20, 2016 · Nifurtimox, developed by Bayer, is a nitrofuran antiprotozoal drug used in the treatment of Chagas disease. On August 6 2020, accelerated FDA approval was granted for its use in pediatric patients in response to promising results from phase III clinical trials.

  4. Nifurtimox is an antiprotozoal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Chagas disease (American Trypanosomiasis), caused by Trypanosoma cruzi, in children who are less than 18 years of age and weigh at least 5.5 lbs. (2.5 kg).

  5. Nifurtimox is used to treat Chagas disease (American Trypanosomiasis) in children. Chagas disease is a potentially life-threatening disease caused by the protozoan parasite, Trypanosoma cruzi, also known as "kissing bug".

  6. www.wikiwand.com › en › NifurtimoxNifurtimox - Wikiwand

    Nifurtimox, sold under the brand name Lampit, is a medication used to treat Chagas disease and sleeping sickness. For sleeping sickness it is used together with eflornithine in nifurtimox-eflornithine combination treatment. In Chagas disease it is a second-line option to benznidazole.

  7. Nifurtimox is used to treat Chagas disease (an infection caused by a parasite) in children from birth to 18 years old who weigh at least 5.5 pounds (2.5 kg). Nifurtimox is in a class of medications called antiprotozoals. It works by killing the organism that can cause Chagas disease. How should this medicine be used?

  8. General information. Nifurtimox is used to treat Chagas’ disease (American trypanosomiasis) [1, 2 ]. For treatment of the acute phase and in congenital cases the recommended dosage is 8–10 mg/kg/day, divided into two or three daily doses, for 30–60 consecutive days.

  1. People also search for